Related Experiment Video
Updated: Jan 17, 2026
![The Synthesis of [Sn10SiSiMe334]2- Using a Metastable SnI Halide Solution Synthesized via a Co-condensation Technique](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F54498.jpg&w=3840&q=50)
The Synthesis of [Sn10SiSiMe334]2- Using a Metastable SnI Halide Solution Synthesized via a Co-condensation Technique
Published on: November 28, 2016
Synthesis of Metformin Hydrosulfide and Its Controlled-Release of H2S
1York University, Department of Biology, Faculty of Science, 151B Farquharson Life Sciences Building, 4700 Keele Street, Toronto, Ontario M3J 1P3, Canada.
Abstract:
Metformin (1,1-dimethylbiguanide) is an effective insulin sensitizer for diabetes management and an antiaging compound. Hydrogen sulfide (H2S) as a gasotransmitter also plays an important role in the regulation of diabetes and longevity. The interaction of these two molecules may find applications in various areas of cell biology. In this study, different preparations of hydrogen sulfide (H2S) were used to interact with metformin to form a metformin hydrosulfide (Metf+HS-), including H2S saturated tetrahydrofuran (THF) solution. H2S demonstrates greater stability in tetrahydrofuran (THF) than in acetone due to THF's moderate polarity, lower evaporation rate, and inert nature, which enhance its solubility and reduce undesired reactions. These properties facilitate controlled H2S release and improved reaction efficiency, making THF a more suitable solvent for H2S-related synthesis processes. Initially, metallic sodium was introduced into anhydrous ethanol under an inert atmosphere, and it reacted to form sodium ethoxide in situ. This freshly generated sodium ethoxide then acted as a strong base, deprotonating metformin hydrochloride to yield the free base form of metformin (1,1-dimethylbiguanide), which precipitated as a white solid after purification steps. This purified compound was subsequently converted into 1,1-dimethylbiguanide hydrosulfide (Metf+HS-) by reacting with a H2S in THF, yielding a slightly odorous, pale-yellow product. H2S release from the Metf+HS- salt was tested in two different solutions, H2O and Dulbecco's Modified Eagle Medium (DMEM), qualified and quantified with a lead acetate paper and a methylene blue spectrophotometry assay, respectively. The results show a higher release of H2S in DMEM than in H2O, likely due to the different solution buffering capacity and ionic strength. The dual functionality of Metf+HS-, combining metformin's own therapeutic properties with the controlled release of H2S, makes it a novel candidate for treating different diseases like diabetes and cardiovascular disorders.
Related Concept Videos
Preparation and Reactions of Sulfides
Drug Metabolism: Phase II Reactions
Oral Hypoglycemic Agents: Sulfonylureas
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

